German Auto Stock News

XTRA:HEI
XTRA:HEIBasic Materials

Heidelberg Materials Shuts Paderborn Plant As Weak Demand Tests Earnings

Heidelberg Materials has decided to close its Paderborn cement plant in Germany. The closure follows weak construction demand that has put pressure on cement volumes in the region. The move reflects a broader effort to adjust the company’s production footprint to current market conditions. For investors watching XTRA:HEI, the closure comes after a volatile period for the share price, with the stock at €174.1 and showing a 21.5% decline year to date and an 18.5% decline over the past month...
XTRA:CBK
XTRA:CBKBanks

Commerzbank Questions Safe Havens As Funding And Valuation Story Evolves

Commerzbank (XTRA:CBK) research flags weaker performance of traditional safe havens during recent market stress linked to Middle East conflict. The bank highlights that government bonds and some currencies have not provided the usual protection during heightened geopolitical risk. The findings point to changing behaviour of classic risk off assets that many investors rely on for portfolio defence. Commerzbank is one of Germany's major lenders, with a large presence in corporate and retail...
XTRA:ALV
XTRA:ALVInsurance

Is Allianz (XTRA:ALV) Offering An Opportunity After Recent Share Price Weakness?

If you are wondering whether Allianz at around €347.60 is offering good value right now, you are not alone. Many investors are trying to work out if the current price fairly reflects the long term story. The stock has seen a 9.1% decline over the past week and a 10.3% decline over the last 30 days, although the 1 year return of 5.7% and 3 year return of 82.8% show a very different picture over longer periods. These moves come as Allianz continues to attract attention in the insurance sector,...
XTRA:MTX
XTRA:MTXAerospace & Defense

Assessing MTU Aero Engines (XTRA:MTX) Valuation After Strong 2025 Sales And Earnings Results

MTU Aero Engines (XTRA:MTX) is back in focus after releasing fourth quarter and full year 2025 results, reporting higher sales, net income and earnings per share compared with the previous year. See our latest analysis for MTU Aero Engines. The latest earnings release has come against a softer backdrop for the shares, with a 30 day share price return of a 6.07% decline and a year to date share price return of a 5.44% decline, even though the 1 year total shareholder return of 7.41% and 5 year...
XTRA:UN0
XTRA:UN0Renewable Energy

Uniper (XTRA:UN0) Valuation Check As Canada LNG Talks Shape Its Energy Diversification Story

Uniper (XTRA:UN0) is back in focus after the state-owned German energy group entered talks with Canada to expand liquefied natural gas purchases, as Berlin seeks broader energy partnerships beyond U.S. supplies. See our latest analysis for Uniper. The LNG talks with Canada come after a mixed period for investors, with a 1-year total shareholder return decline of 26.1% and a 5-year total shareholder return decline of 94.3%, while the year-to-date share price return of 2% suggests only modest...
XTRA:SHA0
XTRA:SHA0Auto Components

Assessing Schaeffler (XTRA:SHA0) Valuation After Mixed 2025 Results And Cautious 2026 Outlook

Schaeffler (XTRA:SHA0) is back in focus after its 2025 earnings, which combined higher gross and EBIT margins and strong free cash flow with a net loss from one off costs and a cautious 2026 outlook. See our latest analysis for Schaeffler. The recent 25.1% 7 day share price decline and 23.7% 30 day share price decline to €7.76 came after guidance and earnings that reset expectations, even though the 1 year total shareholder return of 92.5% still reflects strong past gains. If Schaeffler’s...
XTRA:MRK
XTRA:MRKPharmaceuticals

Merck KGaA XTRA MRK Margin Decline Challenges Bullish Profitability Narratives

Merck KGaA (XTRA:MRK) closed out FY 2025 with fourth quarter revenue of €5.2b and basic EPS of €0.74, while full year trailing twelve month revenue came in at €21.1b with EPS of €6.00, giving investors a clear view of both the latest quarter and the broader run rate. Over recent periods, revenue has moved in a tight band between €5.2b and €5.4b per quarter and quarterly EPS has ranged from €0.74 to €2.07, which helps frame how the current quarter sits against the last few earnings updates...
XTRA:R3NK
XTRA:R3NKMachinery

RENK Group (XTRA:R3NK) Margin Reset To 7.9% Tests Premium P/E Narrative

RENK Group (XTRA:R3NK) has put fresh numbers on the table for FY 2025, with third quarter revenue of €307.6 million, basic EPS of €0.24 and a trailing twelve month EPS of about €1.02 on revenue of roughly €1.29 billion. This is setting the tone for how the rest of the year is being read. The company has seen quarterly revenue move from €272.6 million in Q2 2024 to €347.5 million in Q2 2025, with EPS shifting from €0.10 to €0.30 over the same period. Trailing twelve month net profit margin...
XTRA:IOS
XTRA:IOSIT

Assessing IONOS Group (XTRA:IOS) Valuation After Buybacks And Rising Institutional Ownership

Event driven interest in IONOS Group IONOS Group (XTRA:IOS) is back on investors' radars after two fresh disclosures, continued treasury share purchases under its ongoing buyback program, and Wellington Management Group LLP crossing the 3% voting rights threshold. See our latest analysis for IONOS Group. At a share price of €23.6, IONOS Group has a 1 day share price return of 4.89% and a year to date share price decline of 11.61%, while its 3 year total shareholder return of 47.32% points to...
XTRA:DHL
XTRA:DHLLogistics

DHL Group (XTRA:DHL) EPS Momentum Tests Bullish Margin Expansion Narrative

Deutsche Post (XTRA:DHL) has put fresh numbers on the table for FY 2025, with third quarter revenue at about €20.1b and basic EPS of €0.75, giving investors an updated read on how the business is tracking through the year. The company has seen quarterly revenue move from about €23.3b in Q4 2024 to €21.1b in Q1 2025, €19.5b in Q2 2025 and €20.1b in Q3 2025, while basic EPS shifted from €0.95 to €0.68, €0.72 and then €0.75 over the same stretch, setting up a clear earnings run rate for the year...
HMSE:COP
HMSE:COPHealthcare Services

CompuGroup Medical (HMSE:COP) Margin Compression And 22.5% Earnings Slide Test Bullish Narratives

CompuGroup Medical SE KGaA (HMSE:COP) has wrapped up its FY 2025 update with first half revenue of €593.7 million and basic EPS of €0.31, alongside net income of €16.1 million, giving investors fresh numbers to weigh against a current share price of €27.48. Over recent periods, the company has seen revenue move from €578.8 million in 1H 2024 to €607.5 million in 2H 2024 and €593.7 million in 1H 2025, while basic EPS shifted from €0.62 in 1H 2024 to €0.04 in 2H 2024 and €0.31 in 1H 2025. This...
XTRA:DUE
XTRA:DUEMachinery

Dürr (XTRA:DUE) Quarterly Earnings Swings Put Margin Recovery Narrative To The Test

Dürr (XTRA:DUE) has laid out a mixed set of FY 2025 numbers, with Q3 revenue of €1.0 billion and EPS of €0.36 set against a trailing 12 month EPS loss of €0.91 on revenue of about €4.2 billion. The company has seen quarterly revenue move between €1.0 billion and €1.3 billion since Q2 2024, while EPS has swung from a loss of €1.62 in Q2 2025 to positive readings of €0.24 to €0.45 in other recent quarters. Investors are therefore seeing a picture of a stable top line paired with uneven...
XTRA:IFX
XTRA:IFXSemiconductor

Evaluating Infineon Technologies (XTRA:IFX) Valuation After Recent Share Price Moves

Infineon Technologies: recent performance and business profile Infineon Technologies (XTRA:IFX) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past week, month and past 3 months, prompting investors to reassess its fundamentals. The company operates across automotive, industrial power, power and sensor systems, and connected secure systems. It reported revenue of €14,900.0m and net income of €1,003.0m, figures that help frame current...
XTRA:ADS
XTRA:ADSLuxury

Adidas (XTRA:ADS) Valuation Check After 2025 Earnings Beat Cautious 2026 Outlook And Higher Dividend

adidas (XTRA:ADS) is back in focus after its 2025 earnings release, its cautious 2026 outlook, and a proposed higher dividend, a mix that has coincided with recent share price pressure. See our latest analysis for adidas. That reaction sits against a tough recent run, with adidas’ 7 day share price return of 9.8% and 90 day share price return of 13.1% both in negative territory. The 1 year total shareholder return of 39.1% decline and 5 year total shareholder return of 50.0% decline suggest...
XTRA:PUM
XTRA:PUMLuxury

A Look At PUMA (XTRA:PUM) Valuation After Annual Loss And Ongoing Shareholder Pressure

PUMA (XTRA:PUM) has drawn investor attention after reporting annual revenue of €7.3b alongside a net loss of €673.9m, prompting closer scrutiny of how its global sports and lifestyle business is being reflected in the current share price. See our latest analysis for PUMA. The latest figures land against a mixed price backdrop, with PUMA’s 1 day share price return of 1% decline and 7 day share price return of 5.7% decline contrasting with a 90 day share price return of 6.2% gain. The 1 year...
XTRA:CON
XTRA:CONAuto Components

Continental (XTRA:CON) TTM Loss Of €445 Million Tests Bullish Profitability Narratives

Continental FY 2025 earnings snapshot Continental (XTRA:CON) has wrapped up FY 2025 with fourth quarter revenue of €4,965 million and net income from continuing operations of €13 million, while earnings from discontinued operations contributed €4 million. The company has seen quarterly revenue shift from €10,095 million in Q4 2024 to around the €4,856 million to €4,965 million range across 2025, with Basic EPS moving from €2.15 in Q4 2024 to readings between a loss of €3.78 in Q3 2025 and a...
XTRA:SAX
XTRA:SAXMedia

Ströer SE KGaA (XTRA:SAX) Margin Uptick Tests Bullish Earnings Growth Narrative

Ströer SE KGaA (XTRA:SAX) has wrapped up FY 2025 with fourth quarter revenue of €603.3 million and net income of €65 million, setting the tone for how investors read the year as a whole. Over recent quarters the company has seen revenue move from €475.5 million in Q1 2025 to €504.7 million in Q2 and €491.5 million in Q3. Trailing twelve month revenue sits at about €2.1 billion and net income at €140 million, giving helpful context around the most recent print. With net profit margin at 6.7%...
XTRA:MBG
XTRA:MBGAuto

Mercedes Benz Group (XTRA:MBG) Margin Compression Challenges Bullish Earnings Growth Narrative

Mercedes-Benz Group (XTRA:MBG) FY 2025 earnings snapshot Mercedes-Benz Group (XTRA:MBG) has wrapped up FY 2025 with fourth quarter revenue of €33.7b and basic EPS of €1.43, backed by net income of €1.4b. The company has seen quarterly revenue move from €38.5b and EPS of €2.57 in Q4 2024 to €33.7b and €1.43 in Q4 2025, with FY 2025 quarters ranging between €32.1b and €33.7b of revenue and EPS between €0.95 and €1.74. With trailing net margin sitting at 3.9% versus 7% a year earlier, this set...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Bayer (XTRA:BAYN) Q4 Loss Of €3.8b Tests Earnings Turnaround Narrative

Bayer FY 2025 earnings snapshot Bayer (XTRA:BAYN) has capped FY 2025 with a tough final quarter, posting Q4 revenue of €11.4 billion and a basic EPS loss of €3.80, alongside a net loss of €3.8 billion. Over recent periods, the company has seen quarterly revenue move between €9.7 billion and €13.7 billion, while EPS has swung from a profit of €1.32 in Q1 2025 to losses in each of the following quarters. This keeps the focus firmly on how quickly margins can stabilize. With forecasts in the...
XTRA:SY1
XTRA:SY1Chemicals

Assessing Symrise (XTRA:SY1) Valuation After Results, Dividend Increase, Buyback And Care And Wellness Launch

Symrise (XTRA:SY1) shares are in focus after the company paired its 2025 results with a proposed dividend increase, a new Care & Wellness division, and a €400 million share buyback program. See our latest analysis for Symrise. At a share price of €72.68, Symrise has a 1-day share price return of 2.45% and a year to date share price return of 6.32%. However, the 1-year total shareholder return of 23.13% and 5-year total shareholder return of 24.66% show that longer term holders have faced...
XTRA:SIX2
XTRA:SIX2Transportation

A Look At Sixt (XTRA:SIX2) Valuation After Record 2025 Results And Higher Dividend Proposal

Sixt (XTRA:SIX2) has moved into focus after reporting 2025 earnings, with sales of €4,282.98m and net income of €285.81m, alongside a proposed 18.5% dividend increase. See our latest analysis for Sixt. The 1-day share price return of 4.34% to €67.25 comes after record 2025 results. However, the 1-year total shareholder return of a 21.46% decline and the 3-year total shareholder return of a 39.08% decline suggest momentum has been fading despite recent earnings strength. If this earnings news...
XTRA:LEG
XTRA:LEGReal Estate

LEG Immobilien (XTRA:LEG) One Off Gain Drives Net Margin And Tests Bearish Narratives

LEG Immobilien (XTRA:LEG) has wrapped up FY 2025 with Q4 revenue of €397.3 million and basic EPS of €4.37, while its trailing twelve month figures sit at €1.58 billion of revenue and EPS of €19.44. Over recent periods, revenue has moved from €515.6 million in Q4 2024 to €468.7 million in Q1 2025, €361.7 million in Q2, €351.4 million in Q3 and €397.3 million in Q4, with quarterly EPS ranging from €0.77 to €9.08. As a result, investors are likely to focus on how these swings and the very high...
XTRA:HAG
XTRA:HAGAerospace & Defense

A Look At Hensoldt (XTRA:HAG) Valuation After Raised 2026 Guidance And Higher Dividend Proposal

Hensoldt (XTRA:HAG) is back in focus after raising its 2026 earnings guidance, with the company now targeting around €2,750 million in revenue, along with a higher annual dividend proposal and renewed leadership commitment. See our latest analysis for Hensoldt. Despite the raised 2026 guidance and higher dividend proposal, Hensoldt’s recent news flow has coincided with pressure on the share price. A 1 month share price return of 10.69% and a 7 day share price return of 6.26% indicate that...
XTRA:MRK
XTRA:MRKPharmaceuticals

Assessing Merck KGaA (XTRA:MRK) Valuation After Latest Earnings And Life Science Growth

Merck KGaA (XTRA:MRK) is back in focus after reporting fourth quarter and full year 2025 results. The latest sales and earnings figures give investors fresh data on its Life Science, Healthcare and Electronics segments. See our latest analysis for Merck KGaA. The earnings release appears to have reset expectations, with a 1-day share price return of an 8% decline and a 1-year total shareholder return of an 18.41% decline, indicating that pressure has been building rather than easing. If Merck...